n(1)-methylnicotinamide has been researched along with cyclosporine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballardie, FW; Chalmers, RJ; Daley-Yates, PT; Edwards, BD; Lawson, RS; Maiza, A; O'Driscoll, JB; Testa, HJ | 1 |
Pritchard, JB; Sweet, DH | 1 |
2 other study(ies) available for n(1)-methylnicotinamide and cyclosporine
Article | Year |
---|---|
Altered clearance of N-1 methylnicotinamide associated with the use of low doses of cyclosporine.
Topics: Analysis of Variance; Cyclosporine; Drug Therapy, Combination; Humans; Kidney Function Tests; Kidney Tubules, Proximal; Metabolic Clearance Rate; Niacinamide; Nifedipine; Renal Circulation | 1994 |
rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger.
Topics: Animals; Biological Transport; Carrier Proteins; Cell Membrane; Cells, Cultured; Cyclosporine; Dogs; Female; Gene Library; In Vitro Techniques; Kinetics; Membrane Potentials; Niacinamide; Oocytes; Organic Cation Transport Proteins; Organic Cation Transporter 2; Probenecid; Quinacrine; Quinine; Rats; Recombinant Proteins; Tetraethylammonium; Xenopus laevis | 1999 |